Clinical Research

A BA study allows for the evaluation of the effect of route of administration on patient and then determination of the absolute BA of the drug released from the drug product. The BA for a certain formulation indicates the percentage of the orally supplied dose that is absorbed into the systemic circulation. Absolute Bioavailability is the term used when the reference standard is an IV dosage. Relative Bioavailability is used when the reference standard is any other dose form than IV.

  • Absolute Bioavailability
  • Systemic Circulation
  • IV Dosage

Related Conference of Clinical Research

November 25-26, 2024

10th World Congress on Anesthesia and Critical Care

Paris, France
April 16-17, 2025

9th International Conference on Internal Medicine

Berlin, Germany
May 12-13, 2025

19th International Conference on Obesity Medicine

Toronto, Canada
June 24-25, 2025

3rd Global Summit on HIV-AIDS and STDs

Chicago, USA
July 16-17, 2025

11th World Congress on Medicinal Plants and Marine Drugs

Aix-en-Provence, France
August 07-08, 2025

12th World Summit on Epilepsy and Bipolar Disorders

Paris, France

Clinical Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in